Guanyi Lu

University of Florida — United States

Medicine · Health Sciences

31h-index2.7kcitations101works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Aortic aneurysm repair treatments(49), Aortic Disease and Treatment Approaches(28), Infectious Aortic and Vascular Conditions(18), T-cell and B-cell Immunology(9), Immune Cell Function and Interaction(7)

Publications99 total

Protectin D1/GPR37 signaling enhances macrophage-dependent efferocytosis to attenuate experimental abdominal aortic aneurysm formation
2025
Identifying ARRB2 as a Prognostic Biomarker and Key Player in the Tumor Microenvironment of Pancreatic Cancer through scPagwas Methodology
Current Gene Therapy·2025· 4 cited
130 Systemic lupus erythematosus is a risk factor for having multiple subtypes of cutaneous lupus erythematosus
Journal of Investigative Dermatology·2024
Abstract 3010: Inhibition Of Endothelial Cell-Mediated Efferocytosis Promotes Abdominal Aortic Aneurysm Formation
Arteriosclerosis Thrombosis and Vascular Biology·2024
Methamphetamine use shortens telomere length in male adults and rats
Drug and Alcohol Dependence·2024
Inhibition of Endothelial Cell-Mediated Efferocytosis Promotes Abdominal Aortic Aneurysm Formation
JVS Vascular Science·2024Open Access
Endothelial to mesenchymal transition in the interleukin-1 pathway during aortic aneurysm formation
Journal of Thoracic and Cardiovascular Surgery·2023· 10 citedOpen Access
Neuropeptide S Receptor 1 variant (I107N) regulates behavioral characteristics and NPS effect in mice in a sex-dependent manner
Neuropharmacology·2023· 2 cited
Abstract 521: Pharmacologic Inhibition Of Ferroptosis Attenuates Abdominal Aortic Aneurysm Formation
Arteriosclerosis Thrombosis and Vascular Biology·2023
The association of FKBP5 polymorphisms with the severity of depressive disorder in patients with methamphetamine use disorders
Frontiers in Psychiatry·2023· 1 citedOpen Access
Pharmacologic inhibition by spironolactone attenuates experimental abdominal aortic aneurysms
Frontiers in Cardiovascular Medicine·2023· 18 citedOpen Access
Pharmacologic Inhibition of Ferroptosis Attenuates Abdominal Aortic Aneurysm Formation
JVS Vascular Science·2023Open Access
Sex differences in specialized pro-resolving lipid mediators and their receptors in abdominal aortic aneurysms
JVS Vascular Science·2023· 4 citedOpen Access
Resolution of inflammation via <scp>RvD1</scp> / <scp>FPR2</scp> signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms
The FASEB Journal·2022· 42 citedOpen Access
Abstract 194: Pharmacologic Inhibition By Spironolactone Attenuates Experimental Abdominal Aortic Aneurysms
Arteriosclerosis Thrombosis and Vascular Biology·2022
Endothelial pannexin-1 channels modulate macrophage and smooth muscle cell activation in abdominal aortic aneurysm formation
Nature Communications·2022· 61 citedOpen Access
Abstract 11622: Resolution of Inflammation via Rvd1/fpr2 Signaling in Abdominal Aortic Aneurysms
Circulation·2021
Mesenchymal Stem Cells Alter MicroRNA Expression and Attenuate Thoracic Aortic Aneurysm Formation
Journal of Surgical Research·2021· 9 citedOpen Access
Maresin 1 activates LGR6 signaling to inhibit smooth muscle cell activation and attenuate murine abdominal aortic aneurysm formation
The FASEB Journal·2021· 33 citedOpen Access
Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5/6 nephrectomy models in mice
American Journal of Physiology-Renal Physiology·2021· 69 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Gilbert R. Upchurch(31), Gang Su(22), Gorav Ailawadi(19), Morgan Salmon(15), D. Keith Bishop(13), Ashish K. Sharma(12), Sherri C. Wood(9), William F. Johnston(8), Michael Spinosa(8), Keri Csencsits‐Smith(7), Peter K. Henke(6), Nicolas H. Pope(6), William G. Montgomery(6), Jonathan L. Eliason(5), Karen J. Roelofs(5), Yunge Zhao(5), Castigliano M. Bhamidipati(5), Paul D. DiMusto(5), Adriana Laser(5), Bryna E. Burrell(5)